Cancers of the blood (hematologic malignancies) affect the bone marrow, blood cells, lymph nodes and other parts of the lymphatic system. Malignancies in the blood interfere with normal blood cell production or function. As the cancer cells multiply, they stop your blood from performing essential functions such as fighting off infection.
Decades of scientific research and clinical trials have led to more effective treatments and better outcomes for the more than 150,000 people diagnosed with blood cancers each year. At the University of Chicago Medicine, we’re at the forefront of leading-edge research, the latest clinical trials and the newest treatments for leukemia, lymphoma and multiple myeloma. Our patients have access to advanced treatments not available at most medical centers, such as stem cell transplantation and CAR T-cell therapy, a treatment that supercharges a patient's T cells to recognize and destroy cancer cells. Many patients receive stem cell transplants or CAR T-cell therapy on an outpatient basis, enabling them to return to the comfort of their home or nearby accommodations between treatments and appointments, rather than staying in the hospital.
In 2020 and 2021, the Center for International Bone and Marrow Transplant Research (CIBMTR), an organization dedicated to improving survival, treatment and quality of life for stem cell transplant patients, released annual reports. UChicago Medicine is proud to have had the best one-year outcomes in Chicago and the highest relative to predicted outcomes. The CIBMTR reports now serve as a benchmark for future goals. Learn more about our work to achieve high survival rates for patients.
Offering the Most Advanced Care for Blood Cancers
We care for more than 300 patients with leukemia, myelodysplastic syndromes (MDS) and myeloproliferative neoplasms (MPN) each year, making our program one of the largest in Chicago.
Lymphoma (Hodgkin and Non-Hodgkin)
We are at the forefront of developing new therapies for Hodgkin and non-Hodgkin lymphomas, bringing the newest treatments to our patients as soon as they are available.
New medications, targeted therapies and cellular therapies have changed the landscape for patients with multiple myeloma. UChicago Medicine offers all of the latest treatments for this complex condition.
CAR T-Cell Therapy
CAR T-cell therapy supercharges a patient's white blood cells to find and destroy cancer cells. UChicago Medicine research played a key role in the development of this exciting new immunotherapy.
View videos and learn more
High Performing in Leukemia, Lymphoma and Myeloma
According to U.S. New & World Report's 2023-2024 rankings, UChicago Medicine is high performing in leukemia, lymphoma and myeloma.
Learn more
Convenient Locations for Cancer Care
UChicago Medicine Comer Children's at Edward Hospital
Naperville, IL 60540 1-844-826-5437
Request an Appointment for Cancer Care
– Schedule a virtual video visit to see a provider from the comfort of your home
– Newly diagnosed patients can schedule a 15-minute introductory Express Expert Cancer Opinion virtual session at no cost
– Request an online second opinion from our specialists
To speak to someone directly, please call 1-855-702-8222. If you have symptoms of an urgent nature, please call your doctor or go to the emergency room immediately.
For Referring Physicians
To refer a patient for cancer care, please call UCM Physician Connect at 1-800-824-2282.
* Required Field
